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Molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates in three different Arab world countries 
(West Bank of Palestine, Jordan, and Iraq) was the aim of the study presented here. This is done on the basis of spa sequencing and 
staphylococcal cassette chromosome mec (SCCmec) typing. The majority (92%) of the spa-tested isolates belonged to spa type t932 
and possessed the (SCCmec) type III. These data suggest that MRSA clone, which harbors the spa type t932 and (SCCmec) type III, 
had been transferred throughout the three studied countries.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a 
multidrug-resistant pathogen associated with signifi cant 
morbidity, mortality, and hospitalization costs [1–7]. Cur-
rently, sequence-based methods and protein A-encoding 
gene (spa) typing offer excellent intra- and inter-laborato-
ry reproducibility and the opportunity to compare results 
internationally [8]. Spa typing has also been validated 
for long-term nationwide surveillance studies [9]. To our 
knowledge, no epidemiological surveillance studies have 
investigated the molecular nature of MRSA strains circu-
lating in the health care settings in West Bank of Palestine, 
Jordan, and Iraq. The aims of the present study were to de-
termine the resistance pattern of the current MRSA isolates 
circulating in these countries and to study their molecular 
epidemiology by spa sequencing and SCCmec typing.
Materials and methods
A total of 67 MRSA isolates were isolated between Febru-
ary and September 2010 from several clinical sources in-
cluding the urine, wound, sputum, skin, body fl uids, respi-
ratory tract, and other sources that were randomly selected 
from the largest public tertiary referral hospitals in three 
different Arab world countries (West Bank of Palestine, 
17 isolates; Jordan, 25; and Iraq 25). Figure 1 displays the 
location map of study areas. All isolates were determined 
for mecA, Panton–Valentine leukocidin (PVL) genes, and 
S. aureus-specifi c fragments by multiplex polymerase 
chain reaction (PCR) with GenoType® MRSA-test (Hain 
Lifesciences, Germany) according to the manufacturer’s 
instructions in using the reagents supplied. Briefl y, the 
protocol consisted of DNA isolation, PCR amplifi cation, 
and reverse hybridization, including chemical denatur-
ation of the PCR products, hybridization of the biotinyl-
Fig. 1. Map of the study areas
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ated PCR products to membrane-bound probes, stringent 
washing, adding of streptavidin-alkaline phosphatase (AP) 
conjugate, and an AP-mediated staining reaction.
Antimicrobial susceptibility tests were performed by 
disc diffusion as recommended by the Clinical and Labora-
tory Standard Institute (CLSI) guidelines [10]. Ten antimi-
crobial agents were tested, these were penicillin G (1 μg), 
erythromycin (15 μg), clindamycin (2 μg), vancomycin 
(30 μg), ciprofl oxacin (5 μg), gentamicin (10 μg), cefo-
taxime (30 μg), amikacin (30 μg), teicoplanin (30 μg), and 
sulfamethoxazole-trimethoprim (1.25/23.75 μg). S. aureus 
American Type Culture Collection (ATCC) 25923 was 
used as the control strain in this test.
Spa typing was performed on 12 isolates that included 
representatives of each predominant antibiogram type of 
the three study countries. The polymorphic X region of 
the spa gene was amplifi ed using primers spa-1113f and 
spa-1514r as described previously [11, 12]. The PCR re-
action conditions were as follows: 15 min at 95 °C, 30 
cycles of 1 min at 94 °C, 1 min at 68 °C, 1 min at 72 °C, 
and 10 min at 72 °C. The PCR products were purifi ed us-
ing the MinElute PCR purifi cation kit (Qiagen, Germany), 
and the inserts were sequenced by a dideoxy chain termi-
nation method on an ABI PRISM Model 3130 Sequence 
Instrument at Bethlehem University, Bethlehem, Palestine. 
The Kreiswirth spa nomenclature obtained by the spa typ-
ing tool (http: //fortinbras.us/cgi-bin/spatyper/spaTyper.pl) 
was adopted for the present study.
The nucleotide sequences of 11 isolates reported here 
have been submitted to the GenBank accession numbers 
and were assessed as JX985621, JX985622, JX985623, 
JX985624, JX985625, JX985626, JX985627, JX985628, 
JX985629, JX985630, and JX985631.
SCCmec types were determined by the use of specifi c 
primers for amplifi cation of the key genetic elements as 
described by Ghaznavi-Rad et al. [13]. PCR was per-
formed with a Ready Mix PCR kit (Sigma-Aldrich). Re-
action mixtures contained 2.5 μl template DNA, 12.5 μl 
master mix with 2.5 μl primer mix (1 μM for each primer) 
(Syntezza, Israel), and RNAse-free water to a fi nal vol-
ume of 25 μl. The reaction was carried out in an Eppen-
dorf Mastercycler gradient according to the following 
program: 94 °C for 4 min, 35 cycles of 94 °C for 30 s, 
48 °C for 30 s and 72 °C for 2 min, and a fi nal extension 
at 72 °C for 4 min. PCR products were separated by elec-
trophoresis in agarose 2% gels and stained with ethidium 
bromide.
Results
All the 67 MRSA isolates were positive for mecA and a 
certain type of SCCmec. SCCmec typing identifi ed that 
the majority (95.5%) of isolates carried SCCmec type III 
(n = 64), while three (4.5%) isolates harbored SCCmec 
types V. Panton–Valentin leukocidin (PVL) was detected 
in two (3%) of the Iraq MRSA isolates and were associ-
ated with SCCmec type V. Representative hybridization of 
MRSA isolates with the GenoType MRSA Direct is shown 
in Fig. 2.
As can be deduced from Table 1, the MRSA isolates 
were predominantly resistant to a greater range of antibi-
otics. Of the ten antibiotics tested, isolates indicated ex-
tremely high rate of resistance (above 82%) to penicillin 
G, erythromycin, clindamycin, ciprofl oxacin, gentamicin, 
cefotaxime, and sulfamethoxazole-trimethoprim. Resis-
tance rates of MRSA to other antibiotics were as follows: 
64.2% resistant to amikacin and 13.4% to teicoplanin. No 
vancomycin-resistant S. aureus (VRSA) nor vancomycin-
intermediate S. aureus (VISA) isolates were identifi ed in 
this study.
Table 2 shows the distribution of antibiotic resistance 
patterns of the MRSA isolates by country. The predomi-
nant profi le was represented by 9 (53%), 10 (40%), and 
9 (36%) in the isolates from Palestine, Jordan, and Iraq, 
respectively, with those isolates representing 28 (42%) 
of all isolates. It contained a combination of eight anti-
biotics. These antibiotics are penicillin G, erythromycin, 
clindamycin, ciprofl oxacin, gentamicin, cefotaxime, ami-
kacin, and sulfamethoxazole-trimethoprim.
Interestingly, all the 67 (100%) MRSA isolates were 
noted to be multiply resistant, that is, typically resistant to 
β-lactam plus three or more antibiotics of amikacin, cip-
Fig. 2. Representative hybridization of MRSA isolates with the 
GenoType MRSA Direct. Lane 1: negative control, 2: S. epider-
midis, 3: S. aureus, 4–7: MRSA. A: conjugate control, B: uni-
versal control, C: S. aureus, D: S. epidermidis, E: mec A gene, 
F: PVL gene, respectively
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rofl oxacin, clindamycin, erythromycin, gentamicin, sulfa-
methoxazole-trimethoprim, and teicoplanin.
The genetic association of 12 representatives MRSA 
isolates from the predominant antibiotic resistance pattern 
of the three study countries was investigated by spa typ-
ing. Eleven of these isolates shared a common spa type 
(t932) and were of SCCmec type III, indicating that 11 of 
the 12 isolates (92%) were clonally related (Table 3).
Discussion
The current study was set up to establish the logistics for 
future shared studies that will continue to improve essen-
tial knowledge for clinicians and diagnostic laboratories 
about the cross-border dissemination of multidrug-resis-
tant MRSA clones and their epidemic patterns in neighbor-
ing countries.
Table 1. Resistance to various antibiotics among the MRSA isolates from the Palestine, Jordan, and Iraq countries
Source Percent of isolates resistant to
AMK CIP CLI CTX ERY GEN SXT TPL VAN PEN
Palestine 76.5 94.1 100 100 94.1 94.1 94.1 11.8 0 100
Jordan 60.0 100 100 76.0 96.0 80.0 80.0 16.0 0 100
Iraq 60.0 92.0 100 76.0 96.0 76.0 76.0 12.0 0 100
Total 64.2 95.5 100 82.1 95.5 82.1 82.1 13.4 0 100
AMK: amikacin, CIP: ciprofloxacin, CLI: clindamycin, CTX: cefotaxime, ERY: erythromycin, GEN: gentamicin, 
SXT: sulfamethoxazole-trimethoprim, TPL: teicoplanin, VAN: vancomycin, PEN: penicillin G
Table 2. Patterns of resistance to individual antibiotics among the MRSA isolates from the Palestine, Jordan, and Iraq
Resistance pattern Number of isolates (%)
Palestine 
(n = 17)
Jordan 
(n = 25)
Iraq 
(n = 25)
Total
AMK, CIP, CLI, CTX, ERY, GEN, SXT, PEN 9 (53) 10 (40) 9 (36) 28 (42)
AMK, CIP, CLI, CTX, ERY, GEN, SXT, TPL, PEN 2 (12)  4 (16) 3 (12)  9 (13)
AMK, CLI, CTX, ERY, GEN, SXT, PEN 1 (06)  0 (00) 2 (08)  3 (04)
AMK, CIP, CLI, CTX, GEN, PEN 1 (06)  1 (04) 1 (04)  3 (04)
CIP, CLI, ERY, PEN 0 (00)  2 (08) 4 (16)  6 (09)
CIP, CLI, CTX, ERY, GEN, SXT, PEN 3 (18)  3 (12) 3 (12)  9 (13)
CIP, CLI, CTX, ERY, SXT, PEN 1 (06)  1 (04) 1 (04)  3 (04)
CIP, CLI, ERY, SXT, PEN 0 (00)  2 (08) 1 (04)  3 (04)
CIP, CLI, ERY, GEN, PEN 0 (00)  2 (08) 1 (04)  3 (04)
AMK: amikacin, CIP: ciprofloxacin, CLI: clindamycin, CTX: cefotaxime, ERY: erythromycin, GEN: gentamicin, 
SXT: sulfamethoxazole-trimethoprim, TPL: teicoplanin, VAN: vancomycin, PEN: penicillin G
Table 3. Composition of SCCmec and spa types of 12 MRSA isolates in Palestine,
Jordan, and Iraq
Country Number of 
isolates (%)
spa type SCCmec type
t932 t386 III V
Palestine  4  3 1  3 1
Jordan  4  4 0  4 0
Iraq  4  4 0  4 0
Total 12 11 1 11 1
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The antimicrobial susceptibility patterns of the MRSA 
isolates are a cause for concern as an extremely high rate 
(above 82%) of resistance to penicillin G, erythromycin, 
clindamycin, ciprofl oxacin, gentamicin, cefotaxime, and 
sulfamethoxazole-trimethoprim was observed, a fi nding 
mirrored elsewhere [14, 15].
Of the 10 antibiotics tested, all isolates were complete-
ly sensitive to only vancomycin. Teicoplanin resistance 
was observed in only 13.4% of the isolates. This was not 
surprising since these antibiotics are relatively new, and 
resistance to these antibiotics is currently rare.
The high rate of resistance has major therapeutic impli-
cations, insofar as all the 67 (100%) of our population of 
MRSA isolates show cross-resistance to β-lactams, macro-
lides, ciprofl oxacin, trimethoprim-sulfamethoxazole, and 
aminoglycosides, leaving very few therapeutic options to 
treat infections caused by this microorganism. This phe-
nomenon may be related to the dissemination of trans-
posons with insertion sequences in the 50-kb mec region 
gene [15, 16]. For example, the ability of IS431 elements 
through homologous recombination to trap and cluster re-
sistance determinants with similar IS elements explains 
the multiple drug resistance phenotype that is characteris-
tic of MRSA strains [15, 16].
SCCmec typing showed that SCCmec type III element 
was the predominant type (95.5%), followed by SCCmec 
type V (4.5%). To our knowledge, there has not been 
any previous similar study in the three study countries 
nor neighboring Arab countries to evaluate the SCCmec 
typing results. However, a high prevalence of SCCmec 
type III has been mirrored elsewhere in the world [13]. 
The predominance of SCCmec type III in the three stud-
ied countries may indicate an ancestral origin of MRSA. 
A selected number of isolates – 12 representative MRSA 
isolates from the predominant antibiotic resistance pattern 
of the three study countries – were also analyzed by spa 
typing since it has several advantages in terms of speed, 
ease of use, ease of interpretation, and database creation 
[17].
Eleven of these isolates shared a common spa type 
(t932) and were of SCCmec type III, indicating that 11 of 
the 12 isolates (92%) were clonally related. The regional 
clusters found in the three countries might be explained 
by cross-border patient mobility within these countries in 
general, between Palestine and Jordan in particular, and 
between Iraq and Jordan during and after the 2003 inva-
sion of Iraq. Consequently, the cross-border transfer of 
patients may have an important impact on the dissemina-
tion and prevalence of MRSA in particular clone (t932/
SCCmec III).
In our study, few MRSA isolates (4.5%) carried the 
PVL-toxin genes, and this could be explained by the fact 
that our MRSA isolates were originally hospital acquired. 
Only one of the PVL-positive MRSA isolates, which made 
up 1.5% of the overall sample, belonged to the clone (t932/
SCCmec III). This value, when compared to the overall 
numbers of MRSA, is small but still deserves attention 
since PVL-positive community-associated MRSA (CA-
MRSA) is more commonly associated with skin and soft 
tissue infections [18].
In conclusion, antimicrobial resistance has clearly 
emerged as a serious problem with MRSA in the three 
studied countries, with the type (t932/SCCmec III) being 
the predominant isolates. These results also indicate the 
geographical spread of MRSA over long distances and 
across cultural borders. Thus, continuous surveillance of 
MRSA in hospitals and communities is of great impor-
tance for understanding the epidemiology of MRSA.
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